Clinical Presentations

VCOS 2020 Satellite Symposium: How MyoStrain® Quantifies Segmental Myocardial Strain

October 1, 2020
Virtual Cardio-Oncology Summit 2020
Presented by
Nael Osman, PhD
Founder & Chief Science Officer, Myocardial Solutions, Inc.
Professor of Radiology, Johns Hopkins University

MyoStrain® plays a critical role in clinical decision-making during the cancer process, particularly in patients at risk of heart failure. Presented at the Virtual Cardio-Oncology Summit on October 1st, 2020, leading cardio-oncology experts discuss how MyoStrain may help to stratify cardiotoxicity risk, optimize cardiovascular therapy, prevent and manage cardiotoxicity, and guide long-term survivors’ follow-up.

Sponsored by Myocardial Solutions, Inc., the Satellite Symposium program addresses the medical community's most frequently asked questions surrounding the use of MyoStrain® for protecting cancer patient heart health, providing practical, case-based examples to demonstrate the potential of MyoStrain® to significantly improve transform cardio-oncology care.

See original content